Effect of Nintedanib on Decline in Forced Vital Capacity (FVC) in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) by GAP Stage and ILD-GAP Index | Zendy

AI Assistant Blog Pricing

Effect of Nintedanib on Decline in Forced Vital Capacity (FVC) in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) by GAP Stage and ILD-GAP Index

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.